MedTrace Logo

Mindfulness and Relaxation Interventions in Individual Psychotherapies for Children and Adolescents

NCT04034576 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2025-03-06

No results posted yet for this study

Summary

The study 'Mindfulness and Relaxation interventions in Individual Training Psychotherapies for Children and Adolescents' (MARS-CA) aims to examine the effects of short session-introducing interventions with mindfulness elements (SIIME) on juvenile patients' psychopathological symptomatology and therapeutic alliance at the beginning of the first 24 therapy sessions.

Conditions

  • Hyperkinetic Disorder
  • Depressive Disorder
  • Anxiety Disorder

Interventions

BEHAVIORAL

Cognitive behavior therapy of trainee therapists

In all three treatment arms, trainee therapists perform a cognitive behavior therapy (CBT) under conditions of the German health care system. This treatment is not a manualized intervention, but rather based on individualized treatment plans that have been developed together with expert supervisors during a five session diagnostic stage. Treatment duration is 24 sessions, while on average every fourth is supervized by an CBT expert therapist.

Sponsors & Collaborators

  • Esslingen University of Applied Sciences

    collaborator OTHER

  • Leibniz Institute for Research and Information in Education

    collaborator UNKNOWN

  • Heidelberg University

    lead OTHER

Principal Investigators

  • Julia Kalmar, Dr. · Heidelberg University

  • Johannes Mander, PD Dr. · Heidelberg University

  • Hinrich Bents, Dr. · Heidelberg University

  • Eva Vonderlin, Dr. · Heidelberg University

  • Thomas Heidenreich, Prof. Dr. · University of Applied Sciences Esslingen

  • Sabina Pauen, Prof. Dr. · Heidelberg University

  • Andreas Neubauer, Dr. · Leibniz Institute for Research and Information in Education Frankfurt (Main)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
11 Years
Max Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-08
Primary Completion
2024-05-24
Completion
2024-05-24

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04034576 on ClinicalTrials.gov